Linked Life Data

12380141

Source:http://linkedlifedata.com/resource/pubmed/id/12380141

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
33-34
pubmed:dateCreated
2002-10-16
pubmed:abstractText
The leading symptom of rheumatic diseases is pain. Further common symptoms are swelling, restricted mobility and joint deformation. The aim of treatment is freedom from pain and unrestricted function of the affected parts, together with improved quality of life. Amelioration of pain usually succeeds with the so-called non-steroidal antiinflammatory drugs (NSAIDs). In 10% of the cases, however, these can lead to gastric bleeding and perforation necessitating emergency hospitalization. Approximately 10% of patients with complicated ulcers die. COX-2-inhibitors have an analgesic action equal to that of conventional NSAIDs, but cause appreciably fewer gastrointestinal complications. Comedication of NSAIDs and misoprostol or omeprazole also has a gastric protective effect. Concomitant treatments, provision of aids and relevant information about the disease and its course, help to secure a good outcome. In the last resort, when conservative treatment fails, surgical intervention becomes necessary.
pubmed:commentsCorrections
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1438-3276
pubmed:author
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
144
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
30-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
[Symptomatic therapy of rheumatic diseases. How they reduce pain and thereby safe costs].
pubmed:affiliation
Abt. für Rheumatologie, Klaus Miehlke Klinik, Wiesbaden. wbolten@t-online.de
pubmed:publicationType
Journal Article, English Abstract